Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Items 201–300 of 1,001
Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
Huang, J., Tong, X., Zhang, L., Zhang, Y., Wang, L., Wang, D., Zhang, S., & Fan, H. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.550955 · Cited by 69
“This transition includes the loss of epithelial markers and the acquisition of mesenchymal markers, which leads to functional changes, including cell migration, invasion, and cell cycle arrest (Willis and Borok, 2007; Lovisa et al., 2015; Yang et al., 2020).”
BackgroundPrevalent mesenchymal drift in aging and disease is reversed by partial reprogramming
Lu, J. Y., Tu, W. B., Li, R., Weng, M., Sanketi, B. D., Yuan, B., Reddy, P., Rodriguez Esteban, C., & Izpisua Belmonte, J. C. (2025) · Cell · doi:10.1016/j.cell.2025.07.031 · Cited by 68
Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment
Cabezas‐Sainz, P., Pensado‐López, A., Sáinz, B., & Sanchez, L. E. (2020) · Cells · doi:10.3390/cells9091978 · Cited by 68
“Briefly, in order to acquire the capacity to intravasate and leave the primary tumor, cells undergo a complex transcriptional reprogramming and change their morphology through a process known as epithelial-mesenchymal transition (EMT), increasing their migratory and invasive capacities [4].”
BackgroundLeng, J., Li, H., Niu, Y., Chen, K., Yuan, X., Chen, H., Fu, Z., Zhang, L., Wang, F., Chen, C., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.147990 · Cited by 67
Self-citationMechanisms and pathophysiology of Barrett oesophagus
Souza, R. F., & Spechler, S. J. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00622-w · Cited by 67
Song, Q., Yu, H., Cheng, Y., Han, J., Li, K., Zhuang, J., Lv, Q., Yang, X. F., & Yang, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03508-2 · Cited by 67
“EMT is a key step for epithelial cells to gain invasiveness and an important condition for myometrial invasion and metastasis of BLCA cells [17, 18].”
BackgroundBalamurugan, K., Sehareen, S., Sharan, S., Krishnamurthy, S., Tang, W., McKennett, L., Padmanaban, V., Czarra, K., Ewald, A. J., Ueno, N. T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.156057 · Cited by 67
“A recent guide on the definition of EMT and EMP notes the paucity of investigations that address protein expression and use relevant models such as 3D culture (22).”
Trogisch, F. A., Abouissa, A., Keles, M., Birke, A., Fuhrmann, M., Dittrich, G. M., Weinzierl, N., Wink, E., Cordero, J., Elsherbiny, A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.abq4581 · Cited by 60
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
Tomecka, P., Kunachowicz, D., Górczyńska, J., Gebuza, M., Kuźnicki, J., Skinderowicz, K., & Choromańska, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168972 · Cited by 70
“In the initial epithelial phase, cells exhibit stable connections, and they maintained apical-basal polarity and active interactions with the basal membrane [3].”
BackgroundPlygawko, A. T., Kan, S., & Campbell, K. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0087 · Cited by 66
“These properties, in addition to differences in cytoskeletal organization and interaction with the extracellular matrix, confer a greater migratory capacity on these cells than their epithelial counterparts [11].”
BackgroundSelf-citationCalcium signaling induces a partial EMT
Norgard, R. J., Pitarresi, J. R., Maddipati, R., Aiello, N. M., Balli, D., Li, J., Yamazoe, T., Wengyn, M. D., Millstein, I. D., Folkert, I. W., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051872 · Cited by 66
Self-citationFerroptosis: The Silver Lining of Cancer Therapy
Tang, Z., Huang, Z., Huang, Y., Chen, Y., Huang, M., Liu, H., Ye, Q. A., Zhao, J., & Jia, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.765859 · Cited by 67
“Although chemotherapy has made significant progress in clinical cancer treatment, the epithelial-to-mesenchymal transition, in which tumour cells can metastasise and become resistant to drugs, has limited the effectiveness of anticancer therapies (van Staalduinen et al., 2018; Yang et al., 2020).”
BackgroundPhenotypic plasticity during metastatic colonization
Jehanno, C., Vulin, M., Richina, V., Richina, F., & Bentires‐Alj, M. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.03.007 · Cited by 69
OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor
Fan, C., Wang, Q., van der Zon, G., Ren, J., Agaser, C., Slieker, R. C., Iyengar, P. V., Mei, H., & ten Dijke, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00944-w · Cited by 66
“The acquisition of this hybrid state is described as epithelial–mesenchymal plasticity (EMP), which is also referred to as partial EMT.11,12 The cytokine transforming growth factor-β (TGF-β) is one of the most crucial drivers to induce EMT.5 TGF-β initiates cellular responses by specific binding to cell surface TGF-β…”
BackgroundInfluentialTang, S., Li, S., Liu, T., He, Y., Hu, H., Zhu, Y., Tang, S., & Zhou, H. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.040 · Cited by 65
Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States
Bornes, L., Belthier, G., & van Rheenen, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112403 · Cited by 65
“Definition of EMT-associated terms [5].”
MethodWang, P., Zhou, R., Thomas, P. B., Zhao, L., Zhou, R., Mandal, S., Jolly, M. K., Richard, D. J., Rehm, B. H. A., Ostrikov, K., et al. (2021) · Cancers · doi:10.3390/cancers13122889 · Cited by 65
“Epithelial-mesenchymal transition (EMT) is an important cellular process during organ development through which cells lose their epithelial features at the cellular and molecular levels, and acquire mesenchymal traits such as stellate morphology, reduced adhesion, and increased migration [11].”
BackgroundSelf-citationCadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment
Lin, W., Cooper, L. M., & Anastasiadis, P. Z. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1137013 · Cited by 64
“A vast body of evidence concurs that EMT promotes cell migration and invasion; however, its role in cancer metastasis remains under debate [reviewed in (Lamouille et al., 2014; Brabletz et al., 2018; Yang et al., 2020)].”
BackgroundDong, C., Fang, X., Xiong, J., Zhang, J., Gan, H., Song, C., & Wang, L. (2022) · ACS Nano · doi:10.1021/acsnano.2c03914 · Cited by 63
Tumor microbiome: roles in tumor initiation, progression, and therapy
Zhang, S., Huang, J., Jiang, Z., Tong, H., Ma, X., & Liu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00248-9 · Cited by 63
Zou, H., Shan, C., Ma, L., Liu, J., Yang, N., & Zhao, J. (2020) · PeerJ · doi:10.7717/peerj.10136 · Cited by 63
Self-citationMa, J., van der Zon, G., Gonçalves, M. A. F. V., van Dinther, M., Thorikay, M., Sánchez‐Duffhues, G., & ten Dijke, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.616610 · Cited by 62
Verstappe, J., & Berx, G. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.02.001 · Cited by 62
Self-citationSchiffman, J. S., D’Avino, A. R., Prieto, T., Pang, Y., Fan, Y., Rajagopalan, S., Potenski, C. J., Hara, T., Suvà, M. L., Gawad, C., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01920-6 · Cited by 63
Identification, functional insights and therapeutic targeting of EMT tumour states
Dong, A., & Blanpain, C. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00873-0 · Cited by 62
“EMT equips tumour cells with a higher propensity to adapt to the environment and resist anticancer therapy 2–4 .”
Self-citationBastounis, E. E., Serrano-Alcalde, F., Radhakrishnan, P., Engström, P., Gómez‐Benito, M. J., Oswald, M. S., Yeh, Y., Smith, J. G., Welch, M. D., García‐Aznar, J. M., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.01.012 · Cited by 62
Transcriptional census of epithelial-mesenchymal plasticity in cancer
Cook, D. P., & Vanderhyden, B. C. (2022) · Science Advances · doi:10.1126/sciadv.abi7640 · Cited by 62
Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer
Kopchick, J. J., Basu, R., Berryman, D. E., Jørgensen, J. O. L., Johannsson, G., & Puri, V. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00702-6 · Cited by 61
Hsu, K., Lai, J. C., Chang, J., Peng, P., Huang, C.-H., Lee, D., Tsai, Y.-C., Chung, C., Chang, H., Chang, C.-H., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02819-3 · Cited by 61
“S4d) [41, 42], which was the same set of EMT regulators activated by METTL4 overexpression (Fig.”
BackgroundFerroptosis in Cancer Progression
Zhang, R., Chen, J., Wang, S., Zhang, W., Zheng, Q., & Cai, R. (2023) · Cells · doi:10.3390/cells12141820 · Cited by 62
“As mentioned above, losing of cell–cell junctions and the altering of cell polarity during EMT endow the cancer cells with the ability to migrate, invade into adjacent tissues, intravasate into vascular or lymphatic vessels, and then enter the systemic circulation [26].”
BackgroundEmerging roles of circular RNAs in liver cancer
Louis, C., Leclerc, D., & Coulouarn, C. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100413 · Cited by 60
“CircRNAs in invasion, metastasis and angiogenesis Invasion and metastasis are tightly associated with EMT, a critical cellular process governing the plasticity of epithelial cells which lose adherent junctions, apico-basal polarity and acquire the abilities to resist apoptosis, to invade, and to disseminate.(56,68) Ho…”
BackgroundLineage Plasticity: The New Cancer Hallmark on the Block
Mehta, A., & Stanger, B. Z. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1067 · Cited by 61
Self-citationYu, H., He, J., Su, G., Wang, Y., Fang, F., Yang, W., Gu, K., Fu, N. Y., Wang, Y., Shen, Y., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13061 · Cited by 60
Greaves, D., & Calle, Y. (2022) · Cells · doi:10.3390/cells11040649 · Cited by 60
“This cell behaviour is called epithelial-mesenchymal transition (EMT) and it is critical for tissue morphogenesis during embryonic development and in adulthood for wound healing [1,2].”
BackgroundInfluentialYang, Y., Feng, M., Bai, L., Liao, W., Zhou, K., Zhang, M., Wu, Q., Wen, F., Lei, W., Zhang, P., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03065-0 · Cited by 59
Li, J., Xie, G., Tian, Y., Li, W., Wu, Y., Chen, F., Lin, Y., Lin, X., Au, S. W.-N., Cao, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.019 · Cited by 59
Gungor, M. Z., Uysal, M., & Şentürk, Ş. (2022) · Cancers · doi:10.3390/cancers14040940 · Cited by 58
“Similarly, METTL3induced m6A modifications have also been implicated in the increased cell migration and expression changes of EMT-related genes, such as E-cadherin, fibronectin, and vimentin [252].”
BackgroundKurma, K., & Alix‐Panabières, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1188499 · Cited by 58
“junction proteins, and consequently to disruption of adherent junctions, desmosomes and tight junctions and to loss of apicalbasal polarity (Yang et al., 2020).”
BackgroundKhouzam, R. A., Janji, B., Thiery, J., Zaarour, R. F., Chamseddine, A. N., Mayr, H., Savagner, P., Kiéda, C., Gad, S., Buart, S., et al. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.008 · Cited by 61
Self-citationExosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues
Marima, R. M., Basera, A., Miya, T. V., Damane, B. P., Kandhavelu, J., Mirza, S., Penny, C. B., & Dlamini, Z. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.03.014 · Cited by 58
Elst, L., Philips, G., Vandermaesen, K., Bassez, A., Lodi, F., Vreeburg, M., Brouwer, O. R., Schepers, R., Brussel, T. V., Mohanty, S. K., et al. (2024) · European Urology · doi:10.1016/j.eururo.2024.03.038 · Cited by 58
Endothelium-derived stromal cells contribute to hematopoietic bone marrow niche formation
Kenswil, K. J. G., Pisterzi, P., Sánchez‐Duffhues, G., van Dijk, C., Lolli, A., Knuth, C., Vanchin, B., Jaramillo, A. C., Hoogenboezem, R. M., Sanders, M. A., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.01.006 · Cited by 58
Protein tyrosine phosphatases in cell adhesion
Young, K. A., Biggins, L., & Sharpe, H. J. (2021) · Biochemical Journal · doi:10.1042/bcj20200511 · Cited by 50
Tumor educated platelet: the novel BioSource for cancer detection
Ding, S., Dong, X., & Song, X. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02927-5 · Cited by 58
TGF‐β signaling in liver metastasis
Marvin, D. L., Heijboer, R., ten Dijke, P., & Ritsma, L. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.160 · Cited by 57
You, X., Wang, Y., Meng, J., Han, S., Liu, L., Sun, Y., Zhang, J., Sun, S., Li, X., Sun, W., et al. (2021) · Oncology Reports · doi:10.3892/or.2021.7963 · Cited by 57
Osmulski, P. A., Cunsolo, A., Chen, M., Qian, Y., Lin, C.-L., Hung, C., Mahalingam, D., Kirma, N. B., Chen, C., Taverna, J. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3595 · Cited by 57
“Indeed, the significance of context-dependent EMP for cancer-relevant processes, including CTC invasiveness, is increasingly being acknowledged (5).”
BackgroundInfluentialCheng, K., Seita, Y., Moriwaki, T., Noshiro, K., Sakata, Y., Hwang, Y. S., Torigoe, T., Saitou, M., Tsuchiya, H., Iwatani, C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn8485 · Cited by 57
Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development
Grego‐Bessa, J., Gómez-Apiñániz, P., Prados, B., Gómez, M. J., MacGrogan, D., & de la Pompa, J. L. (2023) · Circulation Research · doi:10.1161/circresaha.123.323321 · Cited by 56
“48 Thus, Nrg1 regulates CM and TM spatial distribution by generating molecularly distinct myocardial layers and establishing trabecular boundaries (Figure 5L).”
BackgroundPapargyriou, A., Najajreh, M., Cook, D. P., Maurer, C. H., Bärthel, S., Messal, H. A., Ravichandran, S. K., Richter, T., Knolle, M. A., Metzler, T., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01273-9 · Cited by 58
“In cancer, tumour cells are able to (re-)activate plasticity programmes to block or revert to terminal-and trans-differentiation processes such as the EMT, a key process in carcinogenesis 13,33,51,52 .”
Ogawa, Y., Kawakami, Y., & Tsubota, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116114 · Cited by 56
Wang, B., Guo, X., Cai, H., Zhu, Y., Huang, L., Wang, W., Luo, L., & Qi, S. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104968 · Cited by 55
Cell–Matrix Interactions in Renal Fibrosis
Kim, K. P., Williams, C. E., & Lemmon, C. A. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2040055 · Cited by 55
“Instead, renal epithelial and endothelial cells are thought to undergo partial EMT, where they express both epithelial and mesenchymal markers without losing their cobblestone morphology, cell–cell contacts, or tubular epithelial structure [23,24].”
Neumann, D., Pillman, K. A., Dredge, B. K., Bert, A. G., Phillips, C. A., Lumb, R., Ramani, Y., Bracken, C. P., Hollier, B. G., Selth, L. A., et al. (2023) · RNA Biology · doi:10.1080/15476286.2023.2294222 · Cited by 55
“Epithelial-mesenchymal transition (EMT) is a developmental process that facilitates cancer progression in epithelial-derived tumours, through the acquisition of mesenchymal features [1].”
Self-citationVimentin intermediate filaments as structural and mechanical coordinators of mesenchymal cells
Guo, M., Wong, I. Y., Moore, A. S., Medalia, O., Lippincott‐Schwartz, J., Weitz, D. A., & Goldman, R. D. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01713-x · Cited by 55
“The basis of such dysregulated EMTs remains poorly understood due to heterogeneous biomarker expression in tumours, as well as the possibility of distinct partial or intermediate EMT states, termed epithelial– mesenchymal plasticity 20 .”
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer
Guerra, E., Trerotola, M., Relli, V., Lattanzio, R., Tripaldi, R., Vacca, G., Ceci, M., Boujnah, K., Garbo, V., Moschella, A., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.07.002 · Cited by 56
Cui, C., Zang, N., Song, J. T., Guo, X., He, Q., Hu, H., Yang, M., Wang, Y., Yang, J., Zou, Y., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200488r · Cited by 55
Self-citationRenaud-Pageot, C., Quivy, J., Lochhead, M., & Almouzni, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.907120 · Cited by 54
“However, tumor cells hijack this process to migrate more efficiently and invade the underlying mesenchyme (Ye et al., 2017; Yang et al., 2020).”
BackgroundThe Role of PTEN in Epithelial–Mesenchymal Transition
Fedorova, O., Parfenyev, S. E., Daks, A. A., Shuvalov, O. Y., & Barlev, N. A. (2022) · Cancers · doi:10.3390/cancers14153786 · Cited by 55
“However, it should be noted that the majority of cancer cells from the primary tumor acquire an intermediate state of EMT or pseudoEMT that is characterized by both epithelial and mesenchymal phenotypes [4].”
BackgroundEbrahimi, N., Manavi, M. S., Faghihkhorasani, F., Fakhr, S. S., Baei, F. J., Khorasani, F. F., Zare, M. M., Far, N. P., Rezaei‐Tazangi, F., Ren, J. T., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10162-7 · Cited by 54
“EMT has a role in tumor progression, metastasis, and resistance to conventional treatments and inhibitors of small-molecule targeted [6, 7].”
Collective cell migration modes in development, tissue repair and cancer
Cheung, K. J., & Horne‐Badovinac, S. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00858-9 · Cited by 54
Hass, R., von der Ohe, J., & Ungefroren, H. (2020) · Cancers · doi:10.3390/cancers12123674 · Cited by 54
Zheng, X., Dai, F., Feng, L., Zou, H., Li, F., & Xu, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.617597 · Cited by 54
“Accordingly, as recommended by the EMT international association, EMT-TFs alone cannot be used as markers of differentiated cell populations, the equivalent of differentiated distant metastases (92).”
BackgroundChong, Z. X., Yeap, S. K., & Ho, W. Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105818 · Cited by 54
Epigenetic basis and targeting of cancer metastasis
Banerjee, R., Smith, J., Eccles, M. R., Weeks, R. J., & Chatterjee, A. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.11.008 · Cited by 54
Function and therapeutic development of exosomes for cancer therapy
Kim, S. B. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01387-1 · Cited by 54
Xie, T., Peng, S., Liu, S., Zheng, M., Diao, W., Ding, M., Fu, Y. S., Guo, H., Zhao, W., & Zhuang, J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01945-9 · Cited by 53
“S2D), both of which were linked to resistance to anoikis or apoptosis [36, 37].”
BackgroundYao, W., Wang, Z., Ma, H., Lin, Y., Liu, X., Li, P., & He, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34269 · Cited by 53
Hydrogen sulfide signaling in regulation of cell behaviors
Wang, Y., Yu, R., Wu, L., & Yang, G. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.07.002 · Cited by 53
Imodoye, S. O., Adedokun, K. A., Muhammed, A. O., Bello, I. O., Muhibi, M. A., Oduola, T., & Oyenike, M. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762817 · Cited by 53
Vishwa, R., BharathwajChetty, B., Girisa, S., Aswani, B. S., Alqahtani, M. S., Abbas, M. A. E., Hegde, M., & Kunnumakkara, A. B. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10170-1 · Cited by 53
“…binary process distinguished either as epithelial or mesenchymal phenotype; however, a more recent understanding suggested that the cells lie in a continuum, allowing cells to exist anywhere in the spectrum of EMT, expressing combined features of both epithelial and mesenchymal phenotypes [48, 49].”
Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
Sarrand, J., & Soyfoo, M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914481 · Cited by 52
Traversa, A., Mari, E., Pontecorvi, P., Gerini, G., Romano, E., Megiorni, F., Amedei, A., Marchese, C., Ranieri, D., & Ceccarelli, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810168 · Cited by 54
“Among the most important transcription factors which spatially and temporally cooperate in the EMT induction, Snail1, Snail2, and ZEB1 are well recognized as master transcription factors, mainly related to the early steps of the process [16].”
BackgroundInfluentialStem Cells in Cancer: From Mechanisms to Therapeutic Strategies
Haddadin, L., & Sun, X. S. (2025) · Cells · doi:10.3390/cells14070538 · Cited by 52
“The epithelial-to-mesenchymal transition (EMT), driven by ZEB1, TWIST, and SNAIL, represses epithelial markers (E-cadherin) and enhances stem-like properties, increasing metastasis, drug resistance, and tumor recurrence [79,80].”
Site‐specific metastasis: A cooperation between cancer cells and the metastatic microenvironment
Izraely, S., & Witz, I. P. (2020) · International Journal of Cancer · doi:10.1002/ijc.33247 · Cited by 53
“This general mechanism may culminate in metastasis formation.(18,61-66)”
BackgroundTaniguchi, N., Ohkawa, Y., Maeda, K., Harada, Y., Nagae, M., Kizuka, Y., Ihara, H., & Ikeda, Y. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100905 · Cited by 52
Huang, X., Xiang, L., Wang, B., Hu, J., Liu, C., Ren, A., Du, K., Ye, G., Liang, Y., Tang, Y., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02787-5 · Cited by 53
Pentimalli, T. M., Schallenberg, S., León-Periñán, D., Legnini, I., Theurillat, I., Thomas, G., Boltengagen, A., Fritzsche, S., Nimo, J., Ruff, L., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101261 · Cited by 52
Partial EMT takes the lead in cancer metastasis
Haerinck, J., & Berx, G. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.11.012 · Cited by 51
Self-citationLiu, B., Liu, T., Liu, Y., Feng, X., Jiang, X., Long, J., Ye, S., Chen, D., Wang, J., & Yang, Z. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69178 · Cited by 50
“cellular process triggered by signals that cells receive from the tumor microenvironment (TME), during which epithelial cells lose their epithelial features and gain mesenchymal phenotypes [6].”
BackgroundCancer-Associated Fibroblast-Like Tumor Cells Remodel the Ewing Sarcoma Tumor Microenvironment
Wrenn, E. D., Apfelbaum, A. A., Rudzinski, E. R., Deng, X., Jiang, W. H., Sud, S., Noord, R. A. V., Newman, E. A., Garcia, N. M., Miyaki, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1111 · Cited by 49
Estradiol Induces Epithelial to Mesenchymal Transition of Human Glioblastoma Cells
Hernández-Vega, A. M., Moral‐Morales, A. D., Zamora-Sánchez, C. J., Piña-Medina, A. G., González‐Arenas, A., & Camacho‐Arroyo, I. (2020) · Cells · doi:10.3390/cells9091930 · Cited by 49
Exosomes in cancer development
Stefanius, K., Servage, K. A., & Orth, K. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.12.018 · Cited by 49
Ge, G., Han, Y., Zhang, J., Li, X., Liu, X., Gong, Y., Lei, Z., Wang, J., Zhu, W., Xu, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202105530 · Cited by 52
Proactive and reactive roles of TGF-β in cancer
Kuburich, N. A., Sabapathy, T., Demestichas, B. R., Maddela, J. J., den Hollander, P., & Mani, S. A. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.08.002 · Cited by 49
Self-citationOpposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
Semenov, O., Daks, A. A., Fedorova, O., Shuvalov, O. Y., & Barlev, N. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.928399 · Cited by 48
“Notably, the cell may acquire an intermediate phenotype characterized by the presence of both epithelial and mesenchymal signs (Yang et al., 2020).”
BackgroundInfluentialKhodaverdi, K., Bakhshi, A., Mozafari, M. R., & Naghib, S. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134962 · Cited by 48
Gly-tRF enhances LCSC-like properties and promotes HCC cells migration by targeting NDFIP2
Zhou, Y., Hu, J., Liu, L., Yan, M., Zhang, Q., Song, X., Yan, L., Zhu, D., Wei, Y., Fu, Z., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02102-8 · Cited by 48
“EMT allows cancer cells to infiltrate into the surrounding tissues and metastasizes [32], cancer cell migration is often accompanied by EMT.”
BackgroundDjediai, S., Suárez, N. G., Cheikh-Hussein, L. E., Torres, S. R., Gresseau, L., Dhayne, S., Joly‐Lopez, Z., & Annabi, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313006 · Cited by 48
Migault, M., Sapkota, S., & Bracken, C. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04199-0 · Cited by 48
“It is therefore inherently difficult to establish a minimal evidential threshold to define an EMT regulator (despite recent attempts [4]) which allows one to question the importance of many proposed regulators that are yet to be substantiated by multiple laboratories, or for which the evidence is dependent upon exogen…”
BackgroundCellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer
Pîrlog, R., Chiroi, P. A., Rusu, I., Jurj, A. M., Budişan, L., Bica, C., Braicu, C., Crişan, D., Sabourin, J., & Berindan‐Neagoe, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105346 · Cited by 48
“Epithelial-to-mesenchymal transition (EMT) is a dynamic process that takes place early in lung cancer tumorigenesis, being an essential step for tumor cells to acquire invasive and metastatic potential [22,23].”
BackgroundThe PLOD2/succinate axis regulates the epithelial–mesenchymal plasticity and cancer cell stemness
Tong, Y., Qi, Y., Xiong, G., Li, J., Scott, T. L., Chen, J., He, D., Li, L., Wang, C., Lane, A. N., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214942120 · Cited by 47
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
Tadić, V., Zhang, W., & Brozović, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189052 · Cited by 47
Exosomes in inflammation and cancer: from bench to bedside applications
Huang, S., Fang, Y., Qiu, Y., Liu, T., Zhang, W., Yang, Y., Zhong, R., Yang, Y., & Peng, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00280-9 · Cited by 47
“EMT is a reversible process that transforms epithelial cells into a quasi-mesenchymal state, characterized by the loss of adhesion, apical-basal polarity, and basal anchoring, alongside the acquisition of migratory and invasive abilities [151].”
Fennell, D. A., Sekido, Y., Baas, P., Husain, A. N., Fontecedro, A. C., Lim, E. K. S., Opitz, I., Simone, C. B., Brims, F., & Wong, M. C. S. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00640-3 · Cited by 47
“Mesothelioma cells that undergo EMT acquire enhanced migratory and invasive properties 67 .”
Building consensus in neuromesodermal research: Current advances and future biomedical perspectives
Binagui-Casas, A., Dias, A., Guillot, C., Metzis, V., & Saunders, D. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.08.003 · Cited by 48
“considering that carcinoma formation is reliant on a multistep process comprising the activation of EMT programs, several of them involving Wnt/b-catenin [11], studying the maintenance and differentiation of cells inside the NMC-populations (e.”
BackgroundInfluentialThe biology of YAP in programmed cell death
Cheng, Y., Mao, M., & Lu, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00365-5 · Cited by 47
“stem cells, resulting in metastatic spread and contributing to clinical therapeutic resistance [104].”
BackgroundEmerging roles of circular RNAs in gastric cancer metastasis and drug resistance
Wang, X., Zhang, J., Cao, G., Hua, J., Shan, G., & Lin, W. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02432-z · Cited by 47
Ramundo, V., Zanirato, G., & Aldieri, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212216 · Cited by 46
“TGFβ could regulate EMT with post-transcriptional mechanisms as well; during TGFβ-induced EMT, miRNA-200, miRNA-34 and miRNA-205 families are downregulated [43,51], so they cannot negatively exert their effect on EMT-TFs, ZEB1 or SNAIL [52].”
BackgroundLOXL2 in Cancer: A Two-Decade Perspective
Cano, A., Eraso, P., Mazón, M. J., & Portillo, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814405 · Cited by 46
Self-citation
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.